EP1009859A1 - Vaccins contre la maladie de lyme - Google Patents

Vaccins contre la maladie de lyme

Info

Publication number
EP1009859A1
EP1009859A1 EP98931370A EP98931370A EP1009859A1 EP 1009859 A1 EP1009859 A1 EP 1009859A1 EP 98931370 A EP98931370 A EP 98931370A EP 98931370 A EP98931370 A EP 98931370A EP 1009859 A1 EP1009859 A1 EP 1009859A1
Authority
EP
European Patent Office
Prior art keywords
polypeptide
burgdorferi
amino acid
polypeptides
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98931370A
Other languages
German (de)
English (en)
Inventor
Gil H. Choi
Alice L. Erwin
Mark S. Hanson
Raju Lathigra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
MedImmune LLC
Original Assignee
Human Genome Sciences Inc
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, MedImmune LLC filed Critical Human Genome Sciences Inc
Publication of EP1009859A1 publication Critical patent/EP1009859A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Cette invention se rapporte à de nouveaux vaccins permettant de prévenir ou d'atténuer la maladie de Lyme. Cette invention se rapporte en outre à des molécules d'acides nucléiques isolées codant des polypeptides antigéniques de Borrelia burgdorferi. Cette invention présente également des polypeptides antigéniques, ainsi que des vecteurs, de cellules hôtes et des procédés de recombinaison pour la production de ceux-ci. Cette invention se rapporte en outre à des procédés de diagnostic pour détecter l'expression de gènes de Borrelia.
EP98931370A 1997-06-20 1998-06-18 Vaccins contre la maladie de lyme Withdrawn EP1009859A1 (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US5035997P 1997-06-20 1997-06-20
US50359P 1997-06-20
US5334497P 1997-07-22 1997-07-22
US5337797P 1997-07-22 1997-07-22
US53377P 1997-07-22
US53344P 1997-07-22
US5748397P 1997-09-03 1997-09-03
US57483P 1997-09-03
PCT/US1998/012718 WO1998059071A1 (fr) 1997-06-20 1998-06-18 Vaccins contre la maladie de lyme

Publications (1)

Publication Number Publication Date
EP1009859A1 true EP1009859A1 (fr) 2000-06-21

Family

ID=27489331

Family Applications (2)

Application Number Title Priority Date Filing Date
EP98931389A Withdrawn EP1012157A1 (fr) 1997-06-20 1998-06-18 POLYUCLEOTIDES DE $i(BORRELIA BURGDORFERI) ET SEQUENCES CORRESPONDANTES
EP98931370A Withdrawn EP1009859A1 (fr) 1997-06-20 1998-06-18 Vaccins contre la maladie de lyme

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP98931389A Withdrawn EP1012157A1 (fr) 1997-06-20 1998-06-18 POLYUCLEOTIDES DE $i(BORRELIA BURGDORFERI) ET SEQUENCES CORRESPONDANTES

Country Status (4)

Country Link
EP (2) EP1012157A1 (fr)
AU (2) AU8153498A (fr)
CA (2) CA2294568A1 (fr)
WO (2) WO1998058943A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492131B1 (en) * 1997-09-10 2002-12-10 Yale University Class I-type lysyl-TRNA synthetase
GB9808423D0 (en) * 1998-04-22 1998-06-17 Glaxo Group Ltd Bacterial polypeptide family
ES2339726T3 (es) * 1998-09-30 2010-05-24 Agensys, Inc. Gen expresado en el cancer de protata.
FR2798386B1 (fr) * 1999-09-10 2003-04-25 Didier Raoult Oligonucleotides monocatenaires, sondes, amorces et procede de detection des spirochetes
AU2001269527A1 (en) * 2000-07-18 2002-01-30 Center For Advanced Science And Technology Incubation, Ltd. Isopentenyl pyrophosphate isomerase
EP1309722A1 (fr) * 2000-08-16 2003-05-14 Markus Fritzsche Utilisation de sequences d'adn microbiennes pouvant identifier des maladies humaines
CN1213061C (zh) 2001-07-13 2005-08-03 一泰医药研究（深圳）有限公司 序列号6的生物活性肽
WO2004005479A2 (fr) * 2002-07-02 2004-01-15 Arizona Board Of Regents Systeme de typage haute resolution pour borrelia pathogene
ES2546484T3 (es) 2005-03-18 2015-09-24 Dsm Ip Assets B.V. Producción de carotenoides en levadura y hongos oleaginosos
WO2008031133A2 (fr) 2006-09-15 2008-03-20 Intercell Ag Antigènes de borrelia
WO2008042338A2 (fr) 2006-09-28 2008-04-10 Microbia, Inc. Production de caroténoïdes dans des levures et des champignons oléagineux
EP2368568A1 (fr) * 2006-11-01 2011-09-28 Immport Therapeutics, INC. Compositions et procédés pour antigènes immunodominants
EP2191266A4 (fr) * 2007-09-07 2011-08-03 Univ California Procédés de diagnostic et de criblage concernant borrelia
JP5931724B2 (ja) 2009-06-29 2016-06-08 ジェノセア バイオサイエンシーズ， インコーポレイテッド ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｎｅｕｍｏｎｉａｅに対するワクチンおよび組成物
EP2665490B1 (fr) 2011-01-20 2020-03-04 Genocea Biosciences, Inc. Vaccins et compositions contre streptococcus pneumoniae
US9816991B2 (en) 2012-02-01 2017-11-14 Biopeptides Corporation Diagnostic peptides for lyme disease
FR3009683A1 (fr) * 2013-08-14 2015-02-20 Univ Strasbourg Vaccins contre la maladie de lyme
WO2016049148A1 (fr) 2014-09-24 2016-03-31 Wellstat Diagnostics, Llc Compositions et méthodes de diagnostic de la maladie de lyme
EP3135295A1 (fr) * 2015-08-28 2017-03-01 Latvian Biomedical Research and Study Centre Couplage de protéines de borrelia bb0689 à particules pseudo-virales pour génération de vaccin contre la maladie de lyme
EP3535412B1 (fr) * 2016-11-03 2021-07-07 University Of Leicester Détection de borréliose sur la base de phages et moyens associés
EP3643796A1 (fr) 2018-10-25 2020-04-29 TBD-diagnostics GmbH Diagnostic de la maladie de lyme

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
CA2025178A1 (fr) * 1989-10-02 1991-04-03 William G. Weisburg Sondes d'acide nucleique pour la detection des spirochetes de la maladie de lyme

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9859071A1 *

Also Published As

Publication number Publication date
AU8151898A (en) 1999-01-04
EP1012157A1 (fr) 2000-06-28
AU8153498A (en) 1999-01-04
WO1998059071A1 (fr) 1998-12-30
WO1998058943A1 (fr) 1998-12-30
CA2294568A1 (fr) 1998-12-30
CA2304925A1 (fr) 1998-12-30

Similar Documents

Publication Publication Date Title
US6607728B2 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
US6913907B2 (en) Enterococcus faecalis polynucleotides encoding EF059
EP1770164B1 (fr) Antigènes et vaccins pour streptococcus pneumoniae
WO1998059071A1 (fr) Vaccins contre la maladie de lyme
WO1998042740A9 (fr) COMPOSES ET PROCEDES DE DIAGNOSTIC ET DE TRAITEMENT DE L'INFECTION PAR $i(EHRLICHIA)
US6277381B1 (en) Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6821754B2 (en) Staphylococcus aureus genes and polypeptides
US6902893B1 (en) Lyme disease vaccines
EP1109911A2 (fr) Genes de staphylococcus aureus et polypeptides associes
US20020086984A1 (en) Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US20020068343A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
US6887663B1 (en) Streptococcus pneumoniae SP036 polynucleotides
US6673356B1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU8938601A (en) Lyme disease polynucleotides
WO1999002700A1 (fr) Gene regulateur a deux composantes - dont l'histidine kinase - issu du candida albicans

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000120

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12Q 1/68 B

Ipc: 7A 61K 39/02 B

Ipc: 7C 07K 16/12 B

Ipc: 7C 12N 15/63 B

Ipc: 7C 12N 15/31 B

Ipc: 7C 07K 14/20 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050322